DRUG · Unmapped registry intervention
ILX651
Find medicine records ·
Find other trials using this name
Clinical trial
Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma
NCT00078455
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Non-Small-Cell Lung Carcinomaunresolved
Interventions
ILX651DRUG
Sponsors & collaborators
Genzyme, a Sanofi Companylead sponsor
Mapped research locations
DallasTexas, United States1NashvilleTennessee, United States1IndianapolisIndiana, United States1AuroraColorado, United States1TucsonArizona, United States1New OrleansLouisiana, United States1Santa MonicaCalifornia, United States1OcalaFlorida, United States1TylerTexas, United States1LubbockTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00078455 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.